Sanofi Canada President and CEO visits BC's Genetic Pathology Evaluation Centre
MONTREAL, Feb. 1, 2012 /CNW Telbec/ - Hugh O'Neill, Sanofi Canada's President and CEO (standing) and Dr. Torsten Nielsen,Co-Director of the Genetic Pathology Evaluation Centre in Vancouver, BC, discuss the latest advances in microarray technology. Sanofi Canada has a ten-year research collaboration with the Centre, supporting their mission to improve cancer diagnosis, assessment and treatment.
Image with caption: "Hugh O'Neill, Sanofi Canada's President and CEO (standing) and Dr. Torsten Nielsen, Co-Director of the Genetic Pathology Evaluation Centre in Vancouver, BC, discuss the latest advances in microarray technology. Sanofi Canada has a ten-year research collaboration with the Centre, supporting their mission to improve cancer diagnosis, assessment and treatment. (CNW Group/Sanofi Canada)". Image available at: http://photos.newswire.ca/images/download/20120201_C8511_PHOTO_EN_9497.jpg
About Sanofi Sanofi is an R&D driven, AI-powered biopharma company committed to improving people's lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around...
Also from this source
Share this article